Literature DB >> 32036579

Differential Expression Hallmarks of Interneurons in Different Types of Focal Cortical Dysplasia.

Chao Liang1, Chun-Qing Zhang1, Xin Chen2, Lu-Kang Wang1, Jiong Yue1, Ning An1, Lei Zhang3, Shi-Yong Liu1, Hui Yang4,5.   

Abstract

Focal cortical dysplasia (FCD) is the main cause of medically intractable pediatric epilepsy. Previous studies have suggested that alteration of cortical interneurons and abnormal cytoarchitecture have been linked to initiation and development for seizure. However, whether each individual subpopulation of cortical interneurons is linked to distinct FCD subtypes remains largely unknown. Here, we retrospectively analyzed both control samples and epileptic specimens pathologically diagnosed with FCD types Ia, IIa, or IIb. We quantified three major interneuron (IN) subpopulations, including parvalbumin (PV)-, somatostatin (Sst)-, and vasoactive intestinal peptide (Vip)-positive INs across all the subgroups. Additionally, we calculated the ratio of the subpopulations of INs to the major INs (mINs) by defining the total number of the PV-, Sst-, and Vip-INs as mINs. Compared with the control, the density of the PV-INs in FCD type IIb was significantly lower, and the ratio of PV/mINs was lower in the superficial part of the cortex of the FCD type Ia and IIb groups. Interestingly, we found a significant increase in the ratio of Vip/mINs only in FCD type IIb. Overall, these results suggest that in addition to a reduction in PV-INs, the increase in Vip/mINs may be related to the initiation of epilepsy in FCD type IIb. Furthermore, the increase in Vip/mINs in FCD type IIb may, from the IN development perspective, indicate that FCD type IIb forms during earlier stages of pregnancy than FCD type Ia.

Entities:  

Keywords:  Development; Focal cortical dysplasia; Pediatric epilepsy; Vasoactive intestinal peptide interneurons

Mesh:

Substances:

Year:  2020        PMID: 32036579     DOI: 10.1007/s12031-020-01492-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  39 in total

Review 1.  Malformations of cortical development: clinical features and genetic causes.

Authors:  Renzo Guerrini; William B Dobyns
Journal:  Lancet Neurol       Date:  2014-06-02       Impact factor: 44.182

2.  Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia.

Authors:  Valentina Medici; Laura Rossini; Francesco Deleo; Giovanni Tringali; Laura Tassi; Francesco Cardinale; Manuela Bramerio; Marco de Curtis; Rita Garbelli; Roberto Spreafico
Journal:  Epilepsia       Date:  2016-05-13       Impact factor: 5.864

3.  Low-grade focal cortical dysplasia is associated with prenatal and perinatal brain injury.

Authors:  Pavel Krsek; Alena Jahodova; Bruno Maton; Prasanna Jayakar; Patricia Dean; Brandon Korman; Gustavo Rey; Catalina Dunoyer; Harry V Vinters; Trevor Resnick; Michael Duchowny
Journal:  Epilepsia       Date:  2010-09-30       Impact factor: 5.864

4.  Immunohistochemical analysis of developmental neural antigen expression in the balloon cells of focal cortical dysplasia.

Authors:  Chang-Woo Han; Byung-Woo Min; Young Kim; Eun-Hui Jeong; Chang-Soo Park; Young-Jong Woo; Hyung-Seok Kim; Min-Cheol Lee
Journal:  J Clin Neurosci       Date:  2010-08-17       Impact factor: 1.961

Review 5.  Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience.

Authors:  Jason T Lerner; Noriko Salamon; Jason S Hauptman; Tonicarlo R Velasco; Marta Hemb; Joyce Y Wu; Raman Sankar; W Donald Shields; Jerome Engel; Itzhak Fried; Carlos Cepeda; Veronique M Andre; Michael S Levine; Hajime Miyata; William H Yong; Harry V Vinters; Gary W Mathern
Journal:  Epilepsia       Date:  2009-01-21       Impact factor: 5.864

6.  A disinhibitory circuit mediates motor integration in the somatosensory cortex.

Authors:  Soohyun Lee; Illya Kruglikov; Z Josh Huang; Gord Fishell; Bernardo Rudy
Journal:  Nat Neurosci       Date:  2013-10-06       Impact factor: 24.884

7.  Different features of histopathological subtypes of pediatric focal cortical dysplasia.

Authors:  Pavel Krsek; Bruno Maton; Brandon Korman; Esperanza Pacheco-Jacome; Prasanna Jayakar; Catalina Dunoyer; Gustavo Rey; Glenn Morrison; John Ragheb; Harry V Vinters; Trevor Resnick; Michael Duchowny
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

8.  Calretinin immunoreactivity in focal cortical dysplasias and in non-malformed epileptic cortex.

Authors:  Filip Barinka; Rastislav Druga; Petr Marusic; Pavel Krsek; Josef Zamecnik
Journal:  Epilepsy Res       Date:  2009-10-24       Impact factor: 3.045

9.  Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.

Authors:  Karin Boer; Paul J Lucassen; Wim G M Spliet; Erno Vreugdenhil; Peter C van Rijen; Dirk Troost; Floor E Jansen; Eleonora Aronica
Journal:  Epilepsia       Date:  2009-07-02       Impact factor: 5.864

Review 10.  Neocortical inhibitory system.

Authors:  R Druga
Journal:  Folia Biol (Praha)       Date:  2009       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.